Clinical Trial Update: Phacoemulsification Combined With Intravitreal Injection of Ranibizumab Prevent Postoperative Capillary Non-perfusion Zone Progress in Non-proliferative Diabetic Retinopathy [Phase 4]

View source ↗

Summary

Phase 4 trial updating outcomes of phacoemulsification with intravitreal ranibizumab to prevent progression of capillary non-perfusion in non-proliferative diab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Diabetic Retinopathy
• Non-proliferative Diabetic Retinopathy

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Ruijin Hospital | Conditions: Mild Non-proliferative Diabetic Retinopathy, Cataract Diabetic | Phase 4 | Status: UNKNOWN